BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 8761883)

  • 1. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
    Elmazar MM; Reichert U; Shroot B; Nau H
    Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-selective retinoid agonists and teratogenic activity.
    Willhite CC; Dawson MI; Reichert U
    Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of retinoic acid receptor gamma to retinoid-induced craniofacial and axial defects.
    Iulianella A; Lohnes D
    Dev Dyn; 1997 May; 209(1):92-104. PubMed ID: 9142499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of RAR-beta 2 gene expression in embryos and RAR-beta 2 transactivation by the synthetic retinoid Ro 13-6307 correlates with its high teratogenic potency.
    Soprano DR; Tairis N; Gyda M; Harnish DC; Jiang H; Soprano KJ; Kochhar DM
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):159-63. PubMed ID: 8397452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
    Elmazar MM; Nau H
    Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratogenesis by retinoic acid analogs positively correlates with elevation of retinoic acid receptor-beta 2 mRNA levels in treated embryos.
    Jiang H; Gyda M; Harnish DC; Chandraratna RA; Soprano KJ; Kochhar DM; Soprano DR
    Teratology; 1994 Jul; 50(1):38-43. PubMed ID: 7974253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (Ro 13-7410): binding affinities and disposition.
    Pignatello MA; Kauffman FC; Levin AA
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):319-27. PubMed ID: 9070355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure.
    Arafa HM; Elmazar MM; Hamada FM; Reichert U; Shroot B; Nau H
    Arch Toxicol; 2000 Jan; 73(10-11):547-56. PubMed ID: 10663386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic control of the development by retinoic acid].
    Mark M; Kastner P; Ghyselinck NB; Krezel W; Dupé V; Chambon P
    C R Seances Soc Biol Fil; 1997; 191(1):77-90. PubMed ID: 9181129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple factors contribute to the toxicity of the aromatic retinoid TTNPB (Ro 13-7410): interactions with the retinoic acid receptors.
    Pignatello MA; Kauffman FC; Levin AA
    Toxicol Appl Pharmacol; 1999 Sep; 159(2):109-16. PubMed ID: 10495774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative disposition, receptor affinity, and teratogenic activity of sulfon arotinoids.
    Willhite CC; Dubois A; Schindler-Horvat J; Apfel C; Eckhoff C
    Teratology; 1995 Sep; 52(3):169-75. PubMed ID: 8638257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid receptor beta,gamma-selective ligands: synthesis and biological activity of 6-substituted 2-naphthoic acid retinoids.
    Yu KL; Spinazze P; Ostrowski J; Currier SJ; Pack EJ; Hammer L; Roalsvig T; Honeyman JA; Tortolani DR; Reczek PR; Mansuri MM; Starrett JE
    J Med Chem; 1996 Jun; 39(12):2411-21. PubMed ID: 8691435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
    Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
    Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-toxicity relationships of the tetramethylated tetralin and indane analogs of retinoic acid.
    Howard WB; Willhite CC; Sharma RP
    Teratology; 1987 Dec; 36(3):303-11. PubMed ID: 3424219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific antagonist of retinoid toxicity in mice.
    Standeven AM; Johnson AT; Escobar M; Chandraratna RA
    Toxicol Appl Pharmacol; 1996 May; 138(1):169-75. PubMed ID: 8658506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
    Lehmann S; Paul C; Törmä H
    Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of retinoic acid (RA) receptor mRNAs in the fetal mouse secondary palate by all-trans and 13-cis RAs: implications for RA-induced teratogenesis.
    Naitoh H; Mori C; Nishimura Y; Shiota K
    J Craniofac Genet Dev Biol; 1998; 18(4):202-10. PubMed ID: 10100049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
    Tian K; Norris AW; Lin CL; Li E
    Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retinoid signalling pathways].
    Fukasawa H; Shudo K
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):555-66. PubMed ID: 8470912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.